Fwd: Give your network free access to your final article

2 views
Skip to first unread message

Dilbag Singh

unread,
Apr 5, 2018, 8:12:44 AM4/5/18
to biomedical-i...@googlegroups.com


with kind regards

Dr Dilbag Singh
Associate Professor

Dept. of Instrumentation & Control Engineering
and
Dept. of Electrical Engineering

Dr B. R. Ambedkar National Institute of Technology
Jalandhar -144011
Mob: 098884 92132

---------- Forwarded message ---------
From: Helen Mary <helen...@gmail.com>
Date: Thu, 5 Apr 2018, 5:29 p.m.
Subject: Fwd: Give your network free access to your final article
To: Dr KK Deepak <kkde...@gmail.com>, Dr Dilbag Singh Dahiya <drdi...@gmail.com>


---------- Forwarded message ----------
From: "Biomedical Signal Processing and Control" <jour...@mail.elsevier.com>
Date: 05-Apr-2018 4:26 PM
Subject: Give your network free access to your final article
To: <helen...@gmail.com>
Cc:

Can't see this email properly? Click here to view an online version

 
Elsevier

Tell your network about your new publication
 
cover

Dear Ms. M C,

Your Share Link for your article undefined is still available for over a month!

To help you access and share your article, we provided you with the following personal article link, which will provide free access to your article for 50 days.

Your personalized Share Link:
https://authors.elsevier.com/a/1WnlZ6DBR2tZqD

Click on the icons below to share with your network:
Facebook Twitter LinkedIn

You are also welcome to email the link to your co-authors and colleagues, or post the link on your own homepage. Anyone who clicks on the link within the 50 day period, will be taken to the final version of your article on ScienceDirect for free. No sign up or registration is needed - just click and read! After this date the Share Link will still work but automatically revert to a link to your full text article.

Yours sincerely, Elsevier Author Support

As an author, you may use your article for a wide range of scholarly, non-commercial purposes, and share and post your article online in a variety of ways. For more information, please see www.elsevier.com/sharing-articles.
 

This message has been sent to helen...@gmail.com from Elsevier Communications on behalf of Elsevier Journals.
If you no longer wish to receive messages of this nature from us in the future, please click here.
Visit the Elsevier Preference Center to manage more of your communication preferences with us.
Copyright © 2018 Elsevier B.V.. All rights reserved. | Elsevier Privacy Policy
Elsevier B.V. Registered Office: Radarweg 29, 1043 NX Amsterdam, The Netherlands. Reg. No. 33158992 – Netherlands. VAT No. NL 005033019B01.

Elsevier

Jignesh G. Bhatt

unread,
Apr 7, 2018, 9:27:59 AM4/7/18
to biomedical-i...@googlegroups.com
Excellent contribution.

Congratulations.

With best regards,

Sincerely yours,

Jignesh G. Bhatt
-------------------------------------------------------------------------------
​---​-----

Prof. Jignesh G. Bhatt
Department of Instrumentation and Control Engineering
Faculty of Technology, Dharmsinh Desai University
Nadiad - 387001, Gujarat, INDIA.
-------------------------------------------------------------------------------
​---​-----

-------------------------------------------------------------------------------
​---​-----

Publications & Citations:
-------------------------------------------------------------------------------
​---​-----


--
--
You received this message because you are subscribed to the Google
Groups "biomedical" group.
To post to this group, send email to
biomedical-intrumentation@googlegroups.com
To unsubscribe from this group, send email to
biomedical-intrumentation+unsub...@googlegroups.com
For more options, visit this group at
http://groups.google.com/group/biomedical-intrumentation?hl=en?hl=en

---
You received this message because you are subscribed to the Google Groups "biomedical" group.
To unsubscribe from this group and stop receiving emails from it, send an email to biomedical-intrumentation+unsub...@googlegroups.com.
For more options, visit https://groups.google.com/d/optout.

Reply all
Reply to author
Forward
0 new messages